Danilov et al. (2024) studied potential loss-of-function ACE mutations (e.g., Arg120fs, Trp314Ter, Asp412fs, Ser1209Profs) in AD patients, which were associated with reduced levels of ACE in the blood. This evidence concerns the gene ACE and Alzheimer disease.